22 reports of this reaction
3.6% of all FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE reports
#6 most reported adverse reaction
OFF LABEL USE is the #6 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, manufactured by HyVee Inc. There are 22 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE to OFF LABEL USE. This represents approximately 3.6% of all 604 adverse event reports for this drug.
Patients taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 22 FDA reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 3.6% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, making it a notable side effect.
If you experience off label use while taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.